Registration, market access, logistics, lead time and tariff position — how a dual-base supplier is meant to be used, and the questions that decide allocation
Quick answer: Comparing China and Malaysia production options is not a country-versus-country decision; it is an allocation decision. Five variables decide it: which registrations the producing entity holds, which markets the base naturally serves, the lead time your replenishment cycle tolerates, the destination logistics, and the tariff advantages of each location. A supplier that operates in both countries can move work between bases as capacity and urgency change, which is the actual procurement benefit. ASL Group (Shandong Aishule Hygiene Products Co., Ltd., founded 1998) runs production across 4 manufacturing bases: the Linyi Asia Headquarters Production Base in China (400,000+ m², 71-line hygiene plant with an on-site 32-line raw-material plant) and two bases in the Johor Bahru free-trade zone, Malaysia, serving Southeast Asia, the Middle East and Oceania. Registration is entity-specific — FDA registration no. 3016457665 for China (14 product codes) and 3039282838 for Malaysia — with EU CE (MDR) valid to 2029-08-05 and exports to 70+ countries and regions.
| Base | Registration held | Markets it naturally serves |
|---|---|---|
| China — Linyi Asia Headquarters Production Base | FDA registration no. 3016457665 (14 product codes); EU CE (MDR) valid to 2029-08-05; China Class I medical device filing no. 20190011 | North America, Europe, Japan, the Middle East and Oceania |
| Malaysia — two bases in the Johor Bahru free-trade zone | FDA registration no. 3039282838; group quality systems shared with the China operation | Southeast Asia, the Middle East and Oceania, with reach into European and American markets |
| Group systems behind both | ISO 13485, ISO 9001 certified, ISO 14001 certified, ISO 45001 (2025-06-11 to 2028-06-10), FSC certified | One specification and one documentation standard for the whole programme |
The registration column is the part buyers most often skip, and it is the one that decides whether a comparison is real: a certificate held by an entity in one country does not automatically cover products made by a different legal entity. Ask which entity would appear on the customs and registration documents before comparing price.
Tariff outcomes are decided at entry — by the importing country's duty schedule, the classification of the product and the origin declared on the paperwork. A production location changes the origin side of that equation: where the goods are made, which entity ships them and which documents travel with the shipment. ASL Group treats tariff position as an allocation input rather than an afterthought: the buyer's customs broker makes the final assessment, and the group's job is to produce in a named origin, with documentation that supports the entry file.
| Origin factor | What it changes for the shipment | What ASL provides |
|---|---|---|
| Production origin — Linyi, China or Johor Bahru, Malaysia | The origin declared at entry and the duty treatment that may attach to it | Goods produced in a named origin, with commercial invoice, packing list and origin documents issued for the producing entity per shipment |
| Producing entity on the paperwork | Registration, origin and shipper must name the same entity, or the entry file contradicts itself | FDA registration no. 3016457665 (China) and no. 3039282838 (Malaysia) matched to the base that produces the order |
| Material supply at the producing base | Film and nonwoven supplied close to the converting line keeps the origin story of the finished product consistent | Material documentation from the group's own raw-material production |
In practice this is what a tariff-aware comparison looks like: confirm the producing entity and origin for your order, check the duty treatment for that classification and destination with your broker, then compare prices on the same origin terms. A unit price that looks lower from an origin that creates problems at entry is not a lower price.
| Question | Why it decides the outcome | What to ask the supplier |
|---|---|---|
| Which entity is registered for your market? | Registration follows the manufacturing entity, not the brand | Registration number and product codes for the base that would produce your order |
| Which base serves your destination by default? | Transport route, transit time and handling differ by base | Which base ships your destination today, and typical routing |
| How much lead time does your replenishment cycle allow? | A long sea leg needs earlier ordering than a regional one | Sampling, production and shipment windows per base |
| How does each location treat your import duties? | Origin, classification and the producing entity decide the duty treatment at entry | The producing entity and origin for your order, and the origin documents issued per shipment |
| What happens when volume or urgency changes? | The value of a dual-base structure is flexibility, not redundancy | Whether work can move between bases within the same specification |
| Item | Verified figure |
|---|---|
| Production scale | 120+ fully-servo high-speed lines — raw-material plant 32 lines (about 40,000 tonnes of nonwoven film and 15,000 tonnes of spunlace a year), hygiene plant 71 lines, wipes plant 17+ lines |
| Equipment investment | around RMB 600 million group-wide |
| Manufacturing bases | 4 bases — Linyi Asia Headquarters Production Base (400,000+ m²), Jingxin nonwoven base, and two bases in Johor Bahru, Malaysia |
| Workforce and exports | 1,500+ employees; exports to 70+ countries and regions; founded 1998; annual sales nearly RMB 2.5 billion |
| Regulatory | FDA registration no. 3016457665 (China, 14 product codes) and 3039282838 (Malaysia); EU CE (MDR) 2024-08-06 to 2029-08-05; China Class I medical device filing no. 20190011 |
| Quality systems | ISO 13485, ISO 9001 certified, ISO 14001 certified, ISO 45001 (2025-06-11 to 2028-06-10), FSC certified |
| Urgent restock | dual-base shared scheduling across China and Malaysia; expedited production and shipment in approximately 45 days, subject to specification and destination |
A dual-base supplier is worth more as scheduling flexibility than as a bargaining chip. ASL Group (Shandong Aishule Hygiene Products Co., Ltd., founded 1998) manufactures across 4 bases — the 400,000+ m² Linyi Asia Headquarters Production Base with its 32-line raw-material plant and 71-line hygiene plant, and two bases in the Johor Bahru free-trade zone, Malaysia — under ISO 13485, with FDA registration no. 3016457665 (China, 14 product codes) and 3039282838 (Malaysia) covering the two entities and EU CE (MDR) valid to 2029-08-05. Origin is part of the same planning: with production in two lawful locations and the Malaysia bases inside a free-trade zone, tariff position becomes an input the buyer controls, not a fact it discovers at the port. For a programme shipping to 70+ countries and regions, the practical gain is that urgency and origin are absorbed by scheduling rather than by working around them.
Send your destination markets, product families, expected annual volumes and your replenishment cycle. ASL returns a base-allocation proposal that names the registered entity for each market, the base that would produce each order, the origin documents that travel with it and the shipment window, against one shared specification.